Collins PW - Search Results

1

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study.

Klamroth R, Windyga J, Radulescu V, Collins PW, Stasyshyn O, Ibrahim HM, Engl W, Tangada SD, Savage W, Ewenstein B. Klamroth R, et al. Among authors: collins pw. Blood. 2021 Apr 1;137(13):1818-1827. doi: 10.1182/blood.2020005673. Blood. 2021. PMID: 33150384 Free PMC article. Clinical Trial.

2

Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis.

Chowdary P, Fischer K, Collins PW, Cotterill A, Konkle BA, Blanchette V, Pipe SW, Berntorp E, Wolfsegger M, Engl W, Spotts G. Chowdary P, et al. Among authors: collins pw. Thromb Haemost. 2020 May;120(5):728-736. doi: 10.1055/s-0040-1709519. Epub 2020 May 5. Thromb Haemost. 2020. PMID: 32369844 Clinical Trial.

3

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.

Björkman S, Oh M, Spotts G, Schroth P, Fritsch S, Ewenstein BM, Casey K, Fischer K, Blanchette VS, Collins PW. Björkman S, et al. Among authors: collins pw. Blood. 2012 Jan 12;119(2):612-8. doi: 10.1182/blood-2011-07-360594. Epub 2011 Oct 31. Blood. 2012. PMID: 22042695 Free article.

4

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.

Valentino LA, Pipe SW, Collins PW, Blanchette VS, Berntorp E, Fischer K, Ewenstein BM, Oh M, Spotts G. Valentino LA, et al. Among authors: collins pw. Haemophilia. 2016 Jul;22(4):514-20. doi: 10.1111/hae.12905. Epub 2016 Mar 1. Haemophilia. 2016. PMID: 26930418 Free article.

5

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens.

Collins PW, Björkman S, Fischer K, Blanchette V, Oh M, Schroth P, Fritsch S, Casey K, Spotts G, Ewenstein BM. Collins PW, et al. J Thromb Haemost. 2010 Feb;8(2):269-75. doi: 10.1111/j.1538-7836.2009.03703.x. Epub 2009 Nov 23. J Thromb Haemost. 2010. PMID: 19943875 Free article.

6

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A.

Shapiro A, Gruppo R, Pabinger I, Collins PW, Hay CR, Schroth P, Casey K, Patrone L, Ehrlich H, Ewenstein BM. Shapiro A, et al. Among authors: collins pw. Expert Opin Biol Ther. 2009 Mar;9(3):273-83. doi: 10.1517/14712590902729392. Expert Opin Biol Ther. 2009. PMID: 19216617

7

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial.

Collins PW, Young G, Knobe K, Karim FA, Angchaisuksiri P, Banner C, Gürsel T, Mahlangu J, Matsushita T, Mauser-Bunschoten EP, Oldenburg J, Walsh CE, Negrier C; paradigm 2 Investigators. Collins PW, et al. Blood. 2014 Dec 18;124(26):3880-6. doi: 10.1182/blood-2014-05-573055. Epub 2014 Sep 26. Blood. 2014. PMID: 25261199 Free PMC article. Clinical Trial.

8

The bleeding phenotype in people with nonsevere hemophilia.

Kloosterman FR, Zwagemaker AF, Bagot CN, Beckers EAM, Castaman G, Cnossen MH, Collins PW, Hay C, Hof M, Laros-van Gorkom B, Leebeek FWG, Male C, Meijer K, Pabinger I, Shapiro S, Coppens M, Fijnvandraat K, Gouw SC. Kloosterman FR, et al. Among authors: collins pw. Blood Adv. 2022 Jul 26;6(14):4256-4265. doi: 10.1182/bloodadvances.2022007620. Blood Adv. 2022. PMID: 35533261 Free PMC article.

9

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management.

Valentino LA, Mamonov V, Hellmann A, Quon DV, Chybicka A, Schroth P, Patrone L, Wong WY; Prophylaxis Study Group. Valentino LA, et al. J Thromb Haemost. 2012 Mar;10(3):359-67. doi: 10.1111/j.1538-7836.2011.04611.x. J Thromb Haemost. 2012. PMID: 22212248 Free PMC article. Clinical Trial.

10

Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study.

Van Der Valk P, Makris M, Fischer K, Tait RC, Chowdary P, Collins PW, Meijer K, van Vulpen LFD, Mauser-Bunschoten E, Schutgens REG. Van Der Valk P, et al. Among authors: collins pw. Blood Adv. 2022 Feb 8;6(3):902-908. doi: 10.1182/bloodadvances.2021005260. Blood Adv. 2022. PMID: 34879394 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page